Endothelin 1

EDN1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesEDN1, ARCND3, ET1, HDLCQ7, PPET1, QME, endothelin 1
External IDsMGI: 95283 HomoloGene: 1476 GeneCards: EDN1
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

1906

13614

Ensembl

ENSG00000078401

ENSMUSG00000021367

UniProt

P05305

P22387

RefSeq (mRNA)

NM_001168319
NM_001955

NM_010104

RefSeq (protein)

NP_001161791
NP_001946

NP_034234

Location (UCSC)Chr 6: 12.29 – 12.3 MbChr 13: 42.3 – 42.31 Mb
PubMed search[1][2]
Wikidata
View/Edit HumanView/Edit Mouse

Endothelin 1 (ET-1), also known as preproendothelin-1 (PPET1), is a potent vasoconstrictor that in humans is encoded by the EDN1 gene and produced by vascular endothelial cells. The protein encoded by this gene is proteolytically processed to release a secreted peptide termed endothelin 1. Endothelin 1 is one of three isoforms of human endothelin.

Preproendothelin is precursor of the peptide ET-1. Endothelial cells convert preproendothelin to proendothelin and subsequently to mature endothelin, which the cells release.[3]

Endothelin-1 receptor antagonists (Bosentan) are used in the treatment of pulmonary hypertension. Inhibition of these receptors prevents pulmonary vasculature constriction and thus decreases pulmonary vascular resistance.

References

  1. "Human PubMed Reference:".
  2. "Mouse PubMed Reference:".
  3. Boulpaep EL, Boron WF (2009). Medical physiology: a cellular and molecular approach. Saunders/Elsevier. ISBN 1-4160-3115-4.

Further reading

  • Bruno CM, Neri S, Di Prima P, Sciacca C (2003). "Pathophysiology of endothelin and medical emergencies.". Panminerva medica. 45 (2): 151–4. PMID 12855940. 
  • Doggrell SA (2006). "The endothelin system and its role in acute myocardial infarction.". Expert Opin. Ther. Targets. 8 (3): 191–201. PMID 15161426. doi:10.1517/14728222.8.3.191. 
  • Beghetti M, Black SM, Fineman JR (2005). "Endothelin-1 in congenital heart disease.". Pediatr. Res. 57 (5 Pt 2): 16R–20R. PMID 15817494. doi:10.1203/01.PDR.0000160447.83332.13. 
  • Cazaubon S, Deshayes F, Couraud PO, Nahmias C (2006). "[Endothelin-1, angiotensin II and cancer]". Med Sci (Paris). 22 (4): 416–22. PMID 16597412. doi:10.1051/medsci/2006224416. 
  • Ariza AC, Bobadilla NA, Halhali A (2007). "[Endothelin 1 and angiotensin II in preeeclampsia]". Rev. Invest. Clin. 59 (1): 48–56. PMID 17569300. 
  • Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ (April 2016). "Endothelin". Pharmacological Reviews. 68 (2): 357–418. PMC 4815360Freely accessible. PMID 26956245. doi:10.1124/pr.115.011833. 

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.